Lilly CEO Dave Ricks recently noted that Foundayo is not more effective than the companys injectable Zepbound, he told CNBC, but its more accessible, its easier to fit into your daily routine. In ATTAIN-1 trials, patients on the highest dose lost an average of 12.4% of their body weight over 72 weeks, compared to the 20%-plus weight loss typically seen with injectable tirzepatide
The drugs work by mimicking the action of the glucagon-like peptide hormone involved in insulin sensitivity and the regulation of blood glucose
BCC and SCC are malignant tumours but typically are not life threatening and are usually successfully treated in doctors offices
GLP-1 drugs can significantly support weight loss and treat symptoms of type 2 diabetes by mimicking a hormone your body naturally uses to regulate your blood sugar and appetite
By combining product versatility with strategic distribution channels, supplement distributors can strengthen market presence, capture consumer demand, and establish a competitive edge in the fast-growing GLP1 and gut health supplement category